11/27/24 16:08 | 11/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 3 | 858 | D | | | | | | | | | | | | | | |
11/27/24 16:06 | 11/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 8 | 126 | D | | | | | | | | | | | | | | |
9/12/24 18:13 | 8/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 3 | 833 | D | | | | | | | | | | | | | | |
9/12/24 18:10 | 8/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 8 | 117 | D | | | | | | | | | | | | | | |
5/29/24 19:12 | 5/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 9 | 108 | D | | | | | | | | | | | | | | |
5/29/24 19:07 | 5/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 3 | 808 | D | | | | | | | | | | | | | | |
2/27/24 19:58 | 2/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 3 | 783 | D | | | | | | | | | | | | | | |
2/27/24 19:56 | 2/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 10 | 99 | D | | | | | | | | | | | | | | |
2/27/24 19:54 | 2/25/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 7 | 102 | D | | | | | | | | | | | | | | |
2/27/24 19:54 | 2/27/24 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -2 | 0.7322 | 0 | -3 | -3 | 102 | D | | | | | | | | | | | | | | |
12/4/23 16:54 | 11/30/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Rothera Mark | CA | DO | P,CEO | P.m | 49 | 0.4936 | 0 | 100 | New | 100 | D | | | | | | | | | | | | | | |
11/28/23 19:06 | 11/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 7 | 99 | D | | | | | | | | | | | | | | |
11/28/23 19:06 | 11/28/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -2 | 0.5000 | 0 | -4 | -4 | 99 | D | | | | | | | | | | | | | | |
11/28/23 19:03 | 11/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 3 | 757 | D | | | | | | | | | | | | | | |
11/28/23 19:01 | 11/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 11 | 90 | D | | | | | | | | | | | | | | |
8/29/23 18:52 | 8/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 4 | 732 | D | | | | | | | | | | | | | | |
8/29/23 18:49 | 8/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 12 | 81 | D | | | | | | | | | | | | | | |
8/29/23 18:47 | 8/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 8 | 96 | D | | | | | | | | | | | | | | |
8/29/23 18:47 | 8/28/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -5 | 1.45 | 0 | -4 | -4 | 96 | D | | | | | | | | | | | | | | |
5/26/23 19:32 | 5/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 4 | 707 | D | | | | | | | | | | | | | | |
5/26/23 19:30 | 5/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 14 | 72 | D | | | | | | | | | | | | | | |
5/26/23 19:29 | 5/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 8 | 92 | D | | | | | | | | | | | | | | |
5/26/23 19:29 | 5/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -5 | 1.42 | 0 | -4 | -4 | 92 | D | | | | | | | | | | | | | | |
2/28/23 18:30 | 2/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 4 | 682 | D | | | | | | | | | | | | | | |
2/28/23 18:28 | 2/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 9 | 48 | D | | | | | | | | | | | | | | |
2/28/23 18:28 | 2/27/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -4 | 1.68 | 0 | -2 | -4 | 48 | D | | | | | | | | | | | | | | |
2/28/23 18:25 | 2/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 17 | 63 | D | | | | | | | | | | | | | | |
2/28/23 18:22 | 2/25/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 8 | 89 | D | | | | | | | | | | | | | | |
2/28/23 18:22 | 2/27/23 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -6 | 1.68 | 0 | -4 | -4 | 89 | D | | | | | | | | | | | | | | |
11/29/22 17:33 | 11/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 9 | 86 | D | | | | | | | | | | | | | | |
11/29/22 17:33 | 11/28/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -10 | 2.72 | 0 | -4 | -4 | 86 | D | | | | | | | | | | | | | | |
11/29/22 17:25 | 11/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 10 | 46 | D | | | | | | | | | | | | | | |
11/29/22 17:25 | 11/28/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -6 | 2.72 | 0 | -2 | -4 | 46 | D | | | | | | | | | | | | | | |
11/29/22 17:21 | 11/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 20 | 54 | D | | | | | | | | | | | | | | |
11/29/22 17:18 | 11/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | D | | M.d | 0 | 0.00 | 0 | 25 | 4 | 657 | D | | | | | | | | | | | | | | |
8/29/22 21:18 | 8/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 10 | 44 | D | | | | | | | | | | | | | | |
8/29/22 21:18 | 8/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -9 | 4.01 | 0 | -2 | -5 | 44 | D | | | | | | | | | | | | | | |
8/29/22 21:16 | 8/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 25 | 45 | D | | | | | | | | | | | | | | |
8/29/22 21:14 | 8/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 9 | 82 | D | | | | | | | | | | | | | | |
8/29/22 21:14 | 8/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -15 | 4.02 | 0 | -4 | -4 | 82 | D | | | | | | | | | | | | | | |
8/29/22 21:11 | 8/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 25 | 4 | 631 | D | | | | | | | | | | | | | | |
8/29/22 21:11 | 8/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | S.d | -54 | 4.01 | 0 | -13 | -2 | 631 | D | | | | | | | | | | | | | | |
5/27/22 17:34 | 5/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 25 | 4 | 620 | D | | | | | | | | | | | | | | |
5/27/22 17:34 | 5/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | S.d | -25 | 1.90 | 0 | -13 | -2 | 620 | D | | | | | | | | | | | | | | |
5/27/22 17:32 | 5/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 11 | 42 | D | | | | | | | | | | | | | | |
5/27/22 17:32 | 5/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -4 | 1.90 | 0 | -2 | -5 | 42 | D | | | | | | | | | | | | | | |
5/27/22 17:27 | 5/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 10 | 79 | D | | | | | | | | | | | | | | |
5/27/22 17:27 | 5/26/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -7 | 1.90 | 0 | -4 | -4 | 79 | D | | | | | | | | | | | | | | |
3/1/22 21:13 | 2/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 25 | 4 | 607 | D | | | | | | | | | | | | | | |
3/1/22 21:13 | 2/28/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | S.d | -41 | 2.78 | 0 | -15 | -2 | 607 | D | | | | | | | | | | | | | | |
3/1/22 21:12 | 2/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 11 | 40 | D | | | | | | | | | | | | | | |
3/1/22 21:12 | 2/28/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -7 | 2.78 | 0 | -2 | -6 | 40 | D | | | | | | | | | | | | | | |
3/1/22 21:11 | 2/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 50 | 27 | D | | | | | | | | | | | | | | |
3/1/22 21:10 | 2/25/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 7 | 10 | 76 | D | | | | | | | | | | | | | | |
3/1/22 21:10 | 2/28/22 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.d | -11 | 2.78 | 0 | -4 | -5 | 76 | D | | | | | | | | | | | | | | |
12/30/21 18:47 | 12/29/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | M.d | 6 | 0.9000 | 0 | 7 | 1 | 597 | D | | | | | | | | | | | | | | |
11/29/21 19:51 | 11/25/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 18 | New | 18 | D | | | | | | | | | | | | | | |
11/29/21 19:50 | 11/25/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 8 | 27 | 38 | D | | | | | | | | | | | | | | |
11/29/21 19:50 | 11/26/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.dm | -22 | 4.81 | 0 | -5 | -11 | 38 | D | | | | | | | | | | | | | | |
11/29/21 19:48 | 11/25/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 0 | 0.00 | 0 | 14 | 23 | 73 | D | | | | | | | | | | | | | | |
11/29/21 19:48 | 11/26/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | S.dm | -36 | 4.81 | 0 | -8 | -9 | 73 | D | | | | | | | | | | | | | | |
11/29/21 19:46 | 11/25/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 50 | 9 | 590 | D | | | | | | | | | | | | | | |
11/29/21 19:46 | 11/26/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | S.dm | -133 | 4.81 | 0 | -28 | -4 | 590 | D | | | | | | | | | | | | | | |
11/15/21 17:59 | 11/15/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Royston Ivor | CA | DO | CEO,P | P | 44 | 5.56 | 0 | 8 | 1 | 567 | D | | | | | | | | | | | | | | |
9/29/21 18:04 | 9/28/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 9 | 0.9000 | 0 | 10 | 18 | 67 | D | | | | | | | | | | | | | | |
6/1/21 17:49 | 5/28/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO,COO | M.d | 11 | 0.9000 | 0 | 12 | 27 | 57 | D | | | | | | | | | | | | | | |
5/13/21 17:46 | 5/11/21 | VIRX | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 49 | 1.40 | 0 | 35 | New | 35 | D | | | | | | | | | | | | | | |
6/5/20 15:18 | 5/29/20 | SNSS | Health | Drug | Pharmaceutical Preparations | Gullotta Tina | CA | O | VP,Finan | P.d | 2 | 0.3315 | 0 | 6 | 41 | 21 | D | | | | | | | | | | | | | | |
4/2/20 15:30 | 5/31/19 | SNSS | Health | Drug | Pharmaceutical Preparations | Quinn William P. | CA | O | See Rema | P.dm | 6 | 0.5058 | 0 | 12 | 10 | 128 | D | | | | | | | | | | | | | | |
7/15/19 16:15 | 7/15/19 | SNSS | Health | Drug | Pharmaceutical Preparations | Aisling Capital Iv, LP | NY | T | | P | 1,500 | 0.6000 | 0 | 2,500 | 33 | 10,100 | I | | | | | | | | | | | | | | |
12/12/18 16:57 | 12/10/18 | SNSS | Health | Drug | Pharmaceutical Preparations | Quinn William P. | CA | O | CFO,Sr.V | P | 19 | 0.4700 | 0 | 40 | 333 | 52 | D | | | | | | | | | | | | | | |
11/6/17 21:27 | 11/2/17 | SNSS | Health | Drug | Pharmaceutical Preparations | Mpm Oncology Impact Management Gp LLC | MA | T | | P.m | 226 | 2.77 | 0 | 82 | 3 | 3,332 | I | | | | | | | | | | | | | | |
10/30/17 19:30 | 10/27/17 | SNSS | Health | Drug | Pharmaceutical Preparations | Misfeldt Dayton | CA | D | | P.d | 800 | 2.00 | 0 | 400 | | 31 | I | | | | | | | | | | | | | | |
12/16/16 17:53 | 12/8/16 | SNSS | Health | Drug | Pharmaceutical Preparations | Parker Geoffrey M. | CA | D | | P.am | 14 | 3.87 | 0 | 4 | 36 | 14 | D | -74 | -30 | 10 | -19 | -2 | -14 | -6 | -3 | 4 | 1 | 10 | 18 | | |
12/12/16 18:43 | 12/8/16 | SNSS | Health | Drug | Pharmaceutical Preparations | Parker Geoffrey M. | CA | D | | P.m | 14 | 3.87 | 0 | 4 | 6 | 66 | D | -72 | -25 | 15 | -18 | 3 | -6 | -4 | -1 | -4 | -4 | 5 | 11 | | |
5/27/16 17:26 | 5/26/16 | SNSS | Health | Drug | Pharmaceutical Preparations | Parker Geoffrey M. | CA | D | | P | 4 | 0.4689 | 0 | 10 | 18 | 62 | D | -91 | -80 | -47 | -37 | -15 | -2 | -6 | -6 | 6 | 28 | 13 | 89 | 44 | |
5/26/16 17:04 | 5/24/16 | SNSS | Health | Drug | Pharmaceutical Preparations | Parker Geoffrey M. | CA | D | | P.m | 25 | 0.4726 | 0 | 53 | New | 53 | D | -90 | -80 | -44 | -34 | -9 | 2 | 0 | 2 | 0 | 22 | 10 | 65 | 43 | |
12/21/15 21:31 | 12/21/15 | SNSS | Health | Drug | Pharmaceutical Preparations | Misfeldt Dayton | CA | D | | P | 1,470 | 0.8400 | 0 | 1,750 | | 139 | I | -81 | -66 | -71 | -25 | -2 | -15 | 5 | 6 | 8 | 8 | -2 | -33 | -34 | -29 |
12/21/15 21:25 | 7/24/15 | SNSS | Health | Drug | Pharmaceutical Preparations | Misfeldt Dayton | CA | D | | S.d | -2,200 | 3.46 | 0 | -636 | -75 | 216 | I | -81 | -66 | -71 | -25 | -2 | -15 | 5 | 6 | 8 | 8 | -2 | -33 | -34 | -29 |
8/26/15 19:54 | 8/24/15 | SNSS | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | CA | DO | P,CEO | P.m | 25 | 1.01 | 0 | 25 | 7 | 379 | I | -79 | -86 | -56 | -58 | -71 | -23 | -14 | -10 | 3 | 12 | 8 | -16 | -29 | -24 |
7/28/15 21:53 | 7/24/15 | SNSS | Health | Drug | Pharmaceutical Preparations | Ketchum Steven B | CA | D | | S.d | -22 | 3.46 | 1 | -6 | -7 | 84 | D | -83 | -84 | -56 | -59 | -61 | -69 | -69 | -70 | 14 | 19 | -14 | -28 | -33 | -64 |
7/28/15 21:52 | 7/24/15 | SNSS | Health | Drug | Pharmaceutical Preparations | Bjerkholt Eric | CA | O | EVP,CFO, | S.d | -22 | 3.46 | 1 | -6 | -5 | 134 | I | -83 | -84 | -56 | -59 | -61 | -69 | -69 | -70 | 14 | 19 | -14 | -28 | -33 | -64 |
7/28/15 21:52 | 7/24/15 | SNSS | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | CA | DO | P,CEO | S.d | -44 | 3.46 | 1 | -13 | -3 | 354 | I | -83 | -84 | -56 | -59 | -61 | -69 | -69 | -70 | 14 | 19 | -14 | -28 | -33 | -64 |
7/28/15 21:52 | 7/24/15 | SNSS | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | CA | DO | P,CEO | P.d | 25 | 1.02 | 1 | 25 | 8 | 354 | I | -83 | -84 | -56 | -59 | -61 | -69 | -69 | -70 | 14 | 19 | -14 | -28 | -33 | -64 |
7/28/15 18:32 | 7/24/15 | SNSS | Health | Drug | Pharmaceutical Preparations | Bay City Capital LLC | CA | T | | S.d | -2,200 | 3.46 | 1 | -636 | -10 | 5,624 | I | -83 | -84 | -56 | -59 | -61 | -69 | -69 | -70 | 14 | 19 | -14 | -28 | -33 | -64 |
8/29/14 18:31 | 8/27/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Misfeldt Dayton | CA | DT | | S.m | -2,399 | 7.98 | 1 | -301 | -77 | 87 | I | 129 | 58 | 17 | 52 | 37 | 16 | 2 | 7 | 0 | -5 | 0 | -67 | -68 | -81 |
8/29/14 18:05 | 8/27/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Craig Adam R | CA | O | EVP,Deve | S | -20 | 8.00 | 1 | -3 | -17 | 13 | D | 129 | 58 | 17 | 52 | 37 | 16 | 2 | 7 | 0 | -5 | 0 | -67 | -68 | -81 |
8/29/14 18:04 | 8/27/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Bjerkholt Eric | CA | O | EVP,CFO, | M.d | 17 | 1.74 | 1 | 10 | 10 | 114 | D | 129 | 58 | 17 | 52 | 37 | 16 | 2 | 7 | 0 | -5 | 0 | -67 | -68 | -81 |
8/29/14 18:04 | 8/27/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Bjerkholt Eric | CA | O | EVP,CFO, | S.d | -80 | 8.00 | 1 | -10 | -8 | 114 | D | 129 | 58 | 17 | 52 | 37 | 16 | 2 | 7 | 0 | -5 | 0 | -67 | -68 | -81 |
8/29/14 18:02 | 8/27/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | CA | DO | P,CEO | M.d | 10 | 2.09 | 1 | 5 | 2 | 283 | D | 129 | 58 | 17 | 52 | 37 | 16 | 2 | 7 | 0 | -5 | 0 | -67 | -68 | -81 |
8/29/14 18:02 | 8/27/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | CA | DO | P,CEO | S.d | -40 | 8.00 | 1 | -5 | -2 | 283 | D | 129 | 58 | 17 | 52 | 37 | 16 | 2 | 7 | 0 | -5 | 0 | -67 | -68 | -81 |
8/29/14 17:42 | 8/27/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Sandell Scott D | MD | T | | S.m | -2,127 | 7.97 | 1 | -267 | -5 | 4,659 | I | 129 | 58 | 17 | 52 | 37 | 16 | 2 | 7 | 0 | -5 | 0 | -67 | -68 | -81 |
8/29/14 17:41 | 8/27/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Kolluri Krishna Kittu | MD | T | | S.m | -2,127 | 7.97 | 1 | -267 | -5 | 4,659 | I | 129 | 58 | 17 | 52 | 37 | 16 | 2 | 7 | 0 | -5 | 0 | -67 | -68 | -81 |
8/29/14 17:41 | 8/27/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Kerins Patrick J | MD | T | | S.m | -2,127 | 7.97 | 1 | -267 | -5 | 4,659 | I | 129 | 58 | 17 | 52 | 37 | 16 | 2 | 7 | 0 | -5 | 0 | -67 | -68 | -81 |
8/29/14 17:40 | 8/27/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Drant Ryan D | MD | T | | S.m | -2,127 | 7.97 | 1 | -267 | -5 | 4,659 | I | 129 | 58 | 17 | 52 | 37 | 16 | 2 | 7 | 0 | -5 | 0 | -67 | -68 | -81 |
8/29/14 17:39 | 8/27/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Baskett Forest | MD | T | | S.m | -2,127 | 7.97 | 1 | -267 | -5 | 4,659 | I | 129 | 58 | 17 | 52 | 37 | 16 | 2 | 7 | 0 | -5 | 0 | -67 | -68 | -81 |
8/29/14 17:39 | 8/27/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Barris Peter J | MD | T | | S.m | -2,127 | 7.97 | 1 | -267 | -5 | 4,659 | I | 129 | 58 | 17 | 52 | 37 | 16 | 2 | 7 | 0 | -5 | 0 | -67 | -68 | -81 |
8/29/14 17:38 | 8/27/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Barrett M James | MD | T | | S.m | -2,127 | 7.97 | 1 | -267 | -5 | 4,659 | I | 129 | 58 | 17 | 52 | 37 | 16 | 2 | 7 | 0 | -5 | 0 | -67 | -68 | -81 |
8/29/14 17:37 | 8/27/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Growth Equity Opportunities Fund, LLC | MD | T | | S.m | -2,127 | 7.97 | 1 | -267 | -5 | 4,659 | D | 129 | 58 | 17 | 52 | 37 | 16 | 2 | 7 | 0 | -5 | 0 | -67 | -68 | -81 |
8/29/14 16:05 | 8/27/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Bay City Capital LLC | CA | T | | S.m | -2,399 | 7.98 | 1 | -301 | -6 | 4,594 | D | 129 | 58 | 17 | 52 | 37 | 16 | 2 | 7 | 0 | -5 | 0 | -67 | -68 | -81 |
8/12/14 20:49 | 8/8/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Misfeldt Dayton | CA | DT | | S.m | -4,938 | 6.64 | 1 | -744 | -89 | 93 | I | 129 | 38 | 45 | 45 | 6 | 18 | 5 | -1 | 4 | 12 | 9 | -74 | -65 | -79 |
8/12/14 17:54 | 8/8/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Bay City Capital LLC | CA | T | | S.m | -4,938 | 6.64 | 1 | -744 | -13 | 4,894 | D | 129 | 38 | 45 | 45 | 6 | 18 | 5 | -1 | 4 | 12 | 9 | -74 | -65 | -79 |
8/12/14 17:45 | 8/8/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Sandell Scott D | MD | T | | S.m | -4,709 | 6.63 | 1 | -711 | -13 | 4,926 | I | 129 | 38 | 45 | 45 | 6 | 18 | 5 | -1 | 4 | 12 | 9 | -74 | -65 | -79 |
8/12/14 17:45 | 8/8/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Kolluri Krishna Kittu | MD | T | | S.m | -4,709 | 6.63 | 1 | -711 | -13 | 4,926 | I | 129 | 38 | 45 | 45 | 6 | 18 | 5 | -1 | 4 | 12 | 9 | -74 | -65 | -79 |
8/12/14 17:44 | 8/8/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Kerins Patrick J | MD | T | | S.m | -4,709 | 6.63 | 1 | -711 | -13 | 4,926 | I | 129 | 38 | 45 | 45 | 6 | 18 | 5 | -1 | 4 | 12 | 9 | -74 | -65 | -79 |
8/12/14 17:44 | 8/8/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Drant Ryan D | MD | T | | S.m | -4,709 | 6.63 | 1 | -711 | -13 | 4,926 | I | 129 | 38 | 45 | 45 | 6 | 18 | 5 | -1 | 4 | 12 | 9 | -74 | -65 | -79 |
8/12/14 17:44 | 8/8/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Baskett Forest | MD | T | | S.m | -4,709 | 6.63 | 1 | -711 | -13 | 4,926 | I | 129 | 38 | 45 | 45 | 6 | 18 | 5 | -1 | 4 | 12 | 9 | -74 | -65 | -79 |
8/12/14 17:44 | 8/8/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Barris Peter J | MD | T | | S.m | -4,709 | 6.63 | 1 | -711 | -13 | 4,926 | I | 129 | 38 | 45 | 45 | 6 | 18 | 5 | -1 | 4 | 12 | 9 | -74 | -65 | -79 |
8/12/14 17:41 | 8/8/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Barrett M James | MD | T | | S.m | -4,709 | 6.63 | 1 | -711 | -13 | 4,926 | I | 129 | 38 | 45 | 45 | 6 | 18 | 5 | -1 | 4 | 12 | 9 | -74 | -65 | -79 |
8/12/14 17:39 | 8/8/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Growth Equity Opportunities Fund, LLC | MD | T | | S.m | -4,709 | 6.63 | 1 | -711 | -13 | 4,926 | D | 129 | 38 | 45 | 45 | 6 | 18 | 5 | -1 | 4 | 12 | 9 | -74 | -65 | -79 |
5/19/14 17:11 | 5/16/14 | SNSS | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | CA | DO | P,CEO | M.d | 51 | 2.09 | 0 | 24 | 9 | 282 | D | 75 | -14 | -9 | 0 | -25 | -8 | -3 | -2 | 1 | 3 | 36 | 51 | -67 | -50 |
4/2/14 19:29 | 11/7/13 | SNSS | Health | Drug | Pharmaceutical Preparations | Ketchum Steven B | CA | D | | M.dm | 63 | 2.09 | 1 | 30 | 68 | 74 | D | 173 | 25 | 36 | 46 | 43 | -5 | -3 | 0 | -3 | -16 | -30 | -9 | 5 | -69 |
4/2/14 19:29 | 11/7/13 | SNSS | Health | Drug | Pharmaceutical Preparations | Ketchum Steven B | CA | D | | S.dm | -152 | 5.05 | 1 | -30 | -29 | 74 | D | 173 | 25 | 36 | 46 | 43 | -5 | -3 | 0 | -3 | -16 | -30 | -9 | 5 | -69 |
6/19/13 19:23 | 6/18/13 | SNSS | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | CA | DO | P,CEO | M.d | 65 | 2.60 | 0 | 25 | 11 | 249 | D | 150 | 89 | 28 | -4 | -6 | -12 | 1 | 1 | -2 | -2 | 5 | -10 | -11 | 23 |
11/30/11 20:34 | 11/28/11 | SNSS | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | CA | DO | P,CEO | P | 3 | 1.14 | 0 | 3 | 2 | 167 | I | -40 | -49 | -61 | -26 | -16 | -11 | -3 | -1 | -2 | 8 | -4 | 45 | 144 | 322 |
11/22/11 13:58 | 11/21/11 | SNSS | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | CA | DO | P,CEO | P | 2 | 1.18 | 0 | 2 | 1 | 158 | D | -39 | -42 | -58 | -11 | -9 | -10 | -5 | -1 | 0 | -2 | 2 | 48 | 135 | 305 |
7/18/11 06:01 | 7/15/11 | SNSS | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | CA | DO | P,CEO | P | 10 | 1.99 | 0 | 5 | 3 | 156 | D | 11 | -32 | -32 | -7 | -34 | -6 | -5 | -2 | 1 | 3 | -23 | -35 | -35 | 63 |
10/8/10 18:40 | 10/8/10 | SNSS | Health | Drug | Pharmaceutical Preparations | Bjerkholt Eric | CA | O | SVP,CFO, | P | 31 | 0.3085 | 0 | 100 | 27 | 464 | I | -65 | -29 | -70 | -39 | -27 | -23 | -32 | -6 | 7 | 7 | 7 | 63 | 18 | -24 |
7/2/10 14:44 | 6/30/10 | SNSS | Health | Drug | Pharmaceutical Preparations | Alta Biopharma Partners III LP | CA | H | Former 1 | P.d | 3,276 | 0.2750 | 0 | 11,912 | 301 | 15,870 | M | -68 | 15 | -58 | -53 | -48 | -13 | -18 | -12 | -2 | 9 | 9 | -7 | 13 | -23 |
7/2/10 12:59 | 6/30/10 | SNSS | Health | Drug | Pharmaceutical Preparations | Kerins Patrick J | MD | T | | P.d | 6,552 | 0.2750 | 0 | 23,824 | 238 | 33,819 | I | -68 | 15 | -58 | -53 | -48 | -13 | -18 | -12 | -2 | 9 | 9 | -7 | 13 | -23 |
7/2/10 12:59 | 6/30/10 | SNSS | Health | Drug | Pharmaceutical Preparations | Kolluri Krishna Kittu | MD | T | | P.d | 6,552 | 0.2750 | 0 | 23,824 | 238 | 33,819 | I | -68 | 15 | -58 | -53 | -48 | -13 | -18 | -12 | -2 | 9 | 9 | -7 | 13 | -23 |
7/2/10 12:59 | 6/30/10 | SNSS | Health | Drug | Pharmaceutical Preparations | Drant Ryan D | MD | T | | P.d | 6,552 | 0.2750 | 0 | 23,824 | 159 | 38,819 | I | -68 | 15 | -58 | -53 | -48 | -13 | -18 | -12 | -2 | 9 | 9 | -7 | 13 | -23 |
7/2/10 12:58 | 6/30/10 | SNSS | Health | Drug | Pharmaceutical Preparations | Baskett Forest | MD | T | | P.d | 6,552 | 0.2750 | 0 | 23,824 | 238 | 33,819 | I | -68 | 15 | -58 | -53 | -48 | -13 | -18 | -12 | -2 | 9 | 9 | -7 | 13 | -23 |
7/2/10 12:57 | 6/30/10 | SNSS | Health | Drug | Pharmaceutical Preparations | Growth Equity Opportunities Fund, LLC | MD | T | | P.d | 6,552 | 0.2750 | 0 | 23,824 | 238 | 33,819 | D | -68 | 15 | -58 | -53 | -48 | -13 | -18 | -12 | -2 | 9 | 9 | -7 | 13 | -23 |
7/1/10 19:58 | 6/30/10 | SNSS | Health | Drug | Pharmaceutical Preparations | Bay City Capital LLC | CA | T | | P.d | 6,552 | 0.2750 | 0 | 23,824 | | 642 | D | -67 | 15 | -59 | -47 | -49 | -13 | -16 | -11 | -4 | 5 | 7 | -8 | 17 | -25 |
7/1/10 19:51 | 6/30/10 | SNSS | Health | Drug | Pharmaceutical Preparations | Misfeldt Dayton | CA | DT | | P.d | 6,552 | 0.2750 | 0 | 23,824 | | 642 | I | -67 | 15 | -59 | -47 | -49 | -13 | -16 | -11 | -4 | 5 | 7 | -8 | 17 | -25 |
7/1/10 19:42 | 6/30/10 | SNSS | Health | Drug | Pharmaceutical Preparations | Ketchum Steven B | CA | O | SVP,R,D | P.d | 66 | 0.2750 | 0 | 238 | 233 | 341 | D | -67 | 15 | -59 | -47 | -49 | -13 | -16 | -11 | -4 | 5 | 7 | -8 | 17 | -25 |
7/1/10 19:33 | 6/30/10 | SNSS | Health | Drug | Pharmaceutical Preparations | Bjerkholt Eric | CA | O | SVP,CFO, | P.d | 66 | 0.2750 | 0 | 238 | 225 | 344 | I | -67 | 15 | -59 | -47 | -49 | -13 | -16 | -11 | -4 | 5 | 7 | -8 | 17 | -25 |
7/1/10 19:25 | 6/30/10 | SNSS | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | CA | DO | P,CEO | P.d | 131 | 0.2750 | 0 | 476 | 198 | 717 | I | -67 | 15 | -59 | -47 | -49 | -13 | -16 | -11 | -4 | 5 | 7 | -8 | 17 | -25 |
5/4/10 18:36 | 4/30/10 | SNSS | Health | Drug | Pharmaceutical Preparations | Semon Dominique | NY | T | | S.d | -374 | 0.9772 | 0 | -383 | -9 | 3,921 | I | -39 | 345 | 158 | 9 | 23 | -2 | -1 | -8 | 3 | 1 | -11 | -45 | -61 | -50 |
4/26/10 11:52 | 12/11/09 | SNSS | Health | Drug | Pharmaceutical Preparations | Semon Dominique | NY | T | | S.dm | -3,794 | 1.65 | 0 | -2,302 | -47 | 2,604 | I | -27 | 375 | 150 | -22 | 12 | -12 | -3 | 3 | 3 | -3 | -17 | -55 | -63 | -59 |
12/16/09 17:20 | 12/14/09 | SNSS | Health | Drug | Pharmaceutical Preparations | Hurwitz Edward | CA | DT | | S | -4,486 | 2.01 | 0 | -2,232 | -100 | 0 | I | -13 | 280 | 317 | 272 | 386 | 465 | 317 | 26 | 15 | -5 | -8 | -39 | -45 | -59 |
12/16/09 17:17 | 12/14/09 | SNSS | Health | Drug | Pharmaceutical Preparations | Alta Biopharma Partners III LP | CA | T | | S | -4,486 | 2.01 | 0 | -2,232 | -100 | 0 | M | -13 | 280 | 317 | 272 | 386 | 465 | 317 | 26 | 15 | -5 | -8 | -39 | -45 | -59 |
7/21/09 16:58 | 7/17/09 | SNSS | Health | Drug | Pharmaceutical Preparations | Warburg Pincus Equity Partners LP | NY | T | | S.dm | -129 | 0.2770 | 0 | -465 | -13 | 3,204 | D | -92 | -84 | -32 | -3 | -40 | -35 | -20 | -7 | 7 | 36 | 46 | 54 | 354 | 68 |
7/17/09 16:04 | 7/15/09 | SNSS | Health | Drug | Pharmaceutical Preparations | Warburg Pincus Equity Partners LP | NY | T | | S.dm | -55 | 0.3080 | 0 | -177 | -5 | 3,670 | D | -91 | -82 | -27 | 67 | -46 | -27 | -21 | -6 | -3 | 13 | 43 | 37 | 337 | 67 |
7/15/09 16:11 | 7/13/09 | SNSS | Health | Drug | Pharmaceutical Preparations | Warburg Pincus Equity Partners LP | NY | T | | S.dm | -165 | 0.3604 | 0 | -457 | -11 | 3,847 | D | -91 | -80 | -24 | 68 | -42 | -18 | -18 | -9 | 0 | -10 | 31 | 28 | 312 | 62 |
5/31/07 12:10 | 5/30/07 | SNSS | Health | Drug | Pharmaceutical Preparations | Leff Jonathan S | CA | D | | P | 3,000 | 4.43 | 0 | 677 | 19 | 4,304 | I | | -36 | -15 | -5 | -13 | -6 | -8 | -6 | 5 | 3 | -15 | -32 | -49 | -51 |
5/31/07 12:09 | 5/30/07 | SNSS | Health | Drug | Pharmaceutical Preparations | Warburg Pincus Equity Partners LP | NY | T | | P | 3,000 | 4.43 | 0 | 677 | 19 | 4,304 | D | | -36 | -15 | -5 | -13 | -6 | -8 | -6 | 5 | 3 | -15 | -32 | -49 | -51 |
3/21/07 18:29 | 3/21/07 | SNSS | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | CA | DO | P,CEO | P | 21 | 4.27 | 0 | 5 | 17 | 35 | D | | -36 | -11 | 5 | -2 | 3 | 10 | 7 | 2 | 1 | 5 | -4 | -37 | -62 |
3/14/07 19:49 | 3/13/07 | SNSS | Health | Drug | Pharmaceutical Preparations | Bjerkholt Eric | CA | O | SVP,Corp | P.a | 13 | 4.30 | 0 | 3 | 117 | 6 | D | | -29 | -31 | -4 | -2 | -9 | -5 | -1 | -5 | 1 | 3 | -2 | -45 | -71 |
3/13/07 20:17 | 3/13/07 | SNSS | Health | Drug | Pharmaceutical Preparations | Bjerkholt Eric | CA | O | SVP,Corp | P | 13 | 4.30 | 0 | 3 | New | 3 | D | | -27 | -29 | -9 | -3 | -10 | -6 | -4 | 5 | 3 | 8 | 2 | -40 | -66 |
12/15/06 17:10 | 12/14/06 | SNSS | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | X1 | DO | P,CEO | P | 75 | 4.18 | 0 | 18 | 131 | 32 | D | | -14 | -29 | -15 | -19 | -12 | -6 | 0 | 12 | 14 | 19 | 6 | 0 | -52 |
9/13/06 19:29 | 9/8/06 | SNSS | Health | Drug | Pharmaceutical Preparations | Wells James A | CA | D | | S | -30 | 6.00 | 0 | -5 | -2 | 321 | D | | | 2 | -3 | 33 | 29 | 13 | 4 | -8 | -9 | -8 | -23 | -25 | -51 |
3/22/06 21:56 | 3/17/06 | SNSS | Health | Drug | Pharmaceutical Preparations | Leff Jonathan S | CA | DT | | P.d | 5,000 | 6.21 | 0 | 805 | 29 | 3,627 | S | | | | | | | | | 0 | 3 | -10 | -12 | -26 | -35 |
3/20/06 16:10 | 3/17/06 | SNSS | Health | Drug | Pharmaceutical Preparations | Warburg Pincus Equity Partners LP | NY | T | | P.d | 5,000 | 6.21 | 0 | 805 | 29 | 3,627 | | | | | | | | | | 4 | 3 | -3 | -10 | -25 | -33 |
2/14/06 11:59 | 9/27/05 | SNSS | Health | Drug | Pharmaceutical Preparations | Biogen Idec Inc | MA | T | | P.d | 5,000 | 7.00 | 0 | 714 | 33 | 2,912 | b | | | | | | | | | 8 | 6 | 22 | 40 | 3 | 2 |
12/22/05 21:47 | 9/30/05 | SNSS | Health | Drug | Pharmaceutical Preparations | Mayfield IX | CA | T | | P.ad | 490 | 7.00 | 0 | 70 | 6 | 1,299 | M | | | | | 3 | -5 | -2 | 5 | -5 | 1 | -2 | 40 | 26 | -3 |
10/4/05 19:14 | 9/30/05 | SNSS | Health | Drug | Pharmaceutical Preparations | Mayfield IX | CA | T | | P.d | 490 | 7.00 | 0 | 70 | 6 | 1,298 | M | | | | | | | | 7 | -2 | -5 | -23 | -24 | 3 | -27 |
10/4/05 17:39 | 9/30/05 | SNSS | Health | Drug | Pharmaceutical Preparations | Leff Jonathan S | CA | DT | | P.d | 3,115 | 7.00 | 0 | 445 | 48 | 1,379 | I | | | | | | | | 7 | -2 | -5 | -23 | -24 | 3 | -27 |
9/30/05 18:12 | 9/30/05 | SNSS | Health | Drug | Pharmaceutical Preparations | Evnin Anthony B | NY | D | | P.d | 945 | 7.00 | 0 | 135 | | 24 | I | | | | | | | | | 0 | -5 | -11 | -27 | 5 | -26 |
9/29/05 15:58 | 9/27/05 | SNSS | Health | Drug | Pharmaceutical Preparations | Warburg Pincus Equity Partners LP | NY | T | | P.d | 3,115 | 7.00 | 0 | 445 | 19 | 2,822 | D | | | | | | | | | 1 | 6 | -4 | -20 | 14 | -20 |